Delivery Order SPE2DB20D2002-SPE2DB25FL76W
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,641.31 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This firm fixed-price, competitively awarded contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The vaccine will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.60 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed price contract was competitively awarded without set-aside provisions and is scheduled for completion by August 28, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $71,577.02 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $36,721.80 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,330.50 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,816.22 for Boostrix TDAP vaccine in 0.5ML syringe format, with an ultimate completion date of June 2, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,258.75 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. This competitive award, made on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed price delivery order with no set-aside designation. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $2,368.54 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes. This non-set-aside, competitively awarded contract operates under firm fixed price terms with a completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a delivery order valued at $97,516.35 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL76WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,469.02 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order is scheduled for completion by September 18, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor with extensive experience fulfilling DLA requirements across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities through competitively awarded contracts. This TDAP vaccine delivery order supports the Defense Health Agency and broader military healthcare system requirements for immunization products, leveraging AmerisourceBergen's established infrastructure and pharmaceutical distribution network to meet ongoing federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.5k | 9/17/25 |